PHARMACOLOGY OF ANAESTHETICS Katarina Zadrazilova FN Brno, October 2013 AIMS OF ANAESTHESIA Triad of anaesthesia •Neuromuscular blocking agents for muscle relaxation •Analgesics/regional anaesthesia for analgesia •Anaesthetic agents to produce unconsciousness • • Why unconscious patient require analgesia ? Overview •Intravenous and inhalational anaesthetics •Analgesics – simple, opioids •Muscle relaxants •Decurarization • • • INTRAVENOUS ANAESTETICS Stages of anaesthetics •Induction – putting asleep •Maintenance – keeping the patient asleep •Reversal – waking up the patient • • Intravenous anaesthetics •Onset of anaesthesia within one arm – brain circulation time – 30 sec •Effect site brain ▫Propofol ▫Thiopentale ▫Etomidate ▫Ketamine General anaesthetic-how do they work •TASK – EXPLAIN 1.Loss of conscious awareness 2.Loss of response to noxious stimuli 3.Reversibility • •Anatomical site of action ▫Brain : thalamus, cortex ▫Spinal cord Meyer-overton.jpg •Linear correlation between the lipid solubility and potency Molecular theories GA – how do they work •Critical volume hypothesis ▫Disruption of the function of ionic channels •Perturbation theory ▫Disruption of annular lipids assoc. with ionic channels •Receptors ▫Inhibitory – GABA A, glycin enhance ▫Excitatory - nAch, NMDA inhibit Molecular theories GA – how do they work GABAA receptor figure6-15.jpg GA – how do they work Thiopentale •Barbiturate •Dose 3-7 mg/kg •Effects : hypnosis, atiepileptic, antanalgesic •Side effects ▫CVS: myocardiac depression, ¯CO ▫Reduction in MV, apnea • Intravenous anaesthetics Thiopentale •Problems with use ▫Extremely painfull and limbtreatening when given intra-arterially ▫Hypersensitivity reactions 1: 15 000 •Contraindications ▫Porphyria • Intravenous anaesthetics •Phenolic derivative •Dose 1- 2.5 mg/kg •Effects : hypnosis •Side effects ▫CVS: myocardiac depression, ¯SVR, ¯CO ▫Respiratory depression ▫Hypersensitivity 1 : 100 000 • • Propofol Propofol •Other effects ▫Pain on induction ▫Nausea and vomiting less likely ▫Better for LMA placement then thiopentale ▫ •Relative contraindications ▫Children under 3 Etomidate •Ester •Dose 0.3 mg/kg •Effects : hypnosis •Side effects ▫CVS: very little effect on HR, CO, SVR ▫Minimal respiratory depression • Etomidate •Problems with use ▫Pain on injection ▫Nausea and vomiting ▫Adrenocortical suppression ▫Hypersensitivity reaction 1: 75 000 ▫ •Relative Contraindications ▫Porphyria • Intravenous anaesthetics Ketamine •Phencyclidine derivative • •CV effects - HR, BP, CO, O2 consumption •RS - RR, preserved laryngeal reflexes •CNS – dissociative anaesthesia, analgesia, amnesia • •Use – analgesic in Emerg. Med Pharmakokinetics •Recovery from single bolus 5-10 min Intravenous anaesthetics Choice of induction agent •1. Are any agents absolutely contraindicated ? ▫Hypersensitivity, porphyria •2. Are there any patient related factors ? ▫CVS status ▫Epilepsy •3. Are there any drug related factors ? ▫Egg allergy • Intravenous anaesthetics Induction + maintenance Intravenous anaesthetics SUMMARY – IV anaesthetics •Mechanism of action – via receptors •Used for anaesthesia and sedation •Used for induction •Propofol used for maintenance as well •Thiopentale, propofol, etomidate •All cause CV and respiratory depression • • • INHALATIONAL ANAESTETICS Anaesthetic gases •Isoflurane •Sevoflurane • •Halothane •Enflurane •Desflurane • •N2O – nitrous oxide Inhalational anaesthetics Anaesthetic gases •Any agent that exists as a liquid at room temperature is a vapour •Any agent that cannot be liquefied at room temperature is a gas ▫ ▫Anaesthetic ‘gases’ are ▫ administered via ▫ vaporizers Inhalational anaesthetics Potency •MAC – that concentration required to prevent 50 % of patients moving when subjected to standart midline incision • •Sevoflurane MAC 1.8 % •Isoflurane MAC 1.17 % Inhalational anaesthetics Potency •MAC – that concentration required to prevent 50 % of patients moving when subjected to standart midline incision • •Sevoflurane MAC 1.8 % •Isoflurane MAC 1.17 % Inhalational anaesthetics Respiratory and cardiovascular effects •All volatile anaesthetics cause ¯ MV and RR •Isoflurane is irritant vapour •¯ SVR, blood pressure falls, HR •Isoflurane - ? Coronary steel Inhalational anaesthetics Metabolism and toxicity •Isoflurane (0.2 %)and Sevoflurane(3.5%) are metabolized by liver •F- ions are produced - ? Renal impairment •Iso and Sevo trigger malignant hyperthermia •N2O ▫Megaloblastic anaemia ▫Teratogenic ▫PONV – Inhalational anaesthetics SUMMARY – inhalational anaesthetics •Mechanism of action – via receptors •Used for induction (sevoflurane) •And maintenance of anaesthesia •Commonly used : Sevoflurane, Isoflurane •Dose dependent CV and respiratory depression •All, but N2O trigger malignant hyperthermia • • • NEUROMUSCULAR BLOCKING AGENTS Neuromuscular blocking agents •Exclusively used in anaesthesia and intensive care •Two classes ▫Depolarizing –succinylcholine ▫Non depolarizing –Vecuronium - aminosteroid –Atracurium - benzylisoquinolinium – Use of NMBs •Tracheal intubation •Surgery where muscle relaxation is essential •Mechanical ventilation Neuromuscular blocking agents Neuromuscular junction Neuromuscular blocking agents Mechanism of action •Depolarizing ▫Structurally related to Ach ▫First activating muscle fibres, then preventing further response • •Non depolarizing •Compete with Ach at nicotinic receptor at the neuromuscular junction Neuromuscular blocking agents Choice for tracheal intubation Elective surgery Emergency surgery Standart induction Rapid sequence induction Non depolarizing agent Succinylcholine Neuromuscular blocking agents Succinylcholine 1 – 2 mg/kg Vecuronium 0.1 mg/kg Atracurium 0.5 mg/kg Intubating doses To maintain paralysis •Non depolarizing muscle relaxants Neuromuscular blocking agents Succinylcholine No Vecuronium 0.02 – 0.03 mg/kg Atracurium 0.1 – 0.2 mg/kg Succinylcholine pharmacokinetics •Duration of action : 3 - 5 min •Metabolism – plasma cholinesterase ▫Cave: suxamethonium apnea • • • ▫ Neuromuscular blocking agents Succinylcholine - adverse effects •Bradycardia •Muscle pain – ‘sux’ pain •Transient raised pressure in eye, stomach and cranium •Raise in potassium ▫ Neuromuscular blocking agents Succinylcholine - contraindications •Patient related contraindications ▫Malignant hyperpyrexia ▫Anaphylaxis to SCh ▫Succinycholine apnea •Clinical contraindications ▫Denervation injury ▫Penetrating eye injury ▫ Neuromuscular blocking agents Non depolarizing muscle relaxants •Choice of NMBs ▫Personal preference ▫Atracurium better in renal or hepatic failure ▫Avoid atracurium in asthmatic patients ▫ ▫ Neuromuscular blocking agents Reversal •Acetylcholine esterase inhibitor – neostigmine ▫Increases concentration of Ach at NMJ •Neostigmine acts at all sites where acetylcholine esterase is present including heart ▫ Neuromuscular blocking agents What effect this might have and how this can be overcome? Neostigmine •Dose of neostigmine – 0.05 mg/kg •In > 50 kg man 2.5 mg •Given with atropine 0.5 mg Neuromuscular blocking agents Peripheral nerve stimulator •Check the depth of neuromuscular blockade •Determine that neuromuscular blockade is reversible •Check that blockade has been reversed safisfactorily Neuromuscular blocking agents SUMMARY – muscle relaxants •Mechanism of action – via acetylcholine receptor •Used to facilitate tracheal intubation, mechanical ventilation and surgery •Depolarizing – Succinylcholine ▫Lots of side effects •Non depolarizing – Vecuronium, Atracurium ▫Minimal CV and Resp. effects • • • ANALGESICS Analgesics •Paracetamol, aspirin •Other Non Steroid Anti Inflamatory Drugs •Opioids • •Local anaesthetics •Antidepressants •Anti-epileptics •Ketamine •Clonidine • NSAIDs - effects •Antipyretic •Anti-inflamatory •Analgesic Simple analgesics •Antipyretic agents found in white willow bark and led to development of aspirin 1899 Aspirin •Anti-inflamatory agent in joint disease •Cardiovascular – unstable angina •Antiplatelet drug - prevention of stroke •Radiation induced diarrhoea •Alzheimer’s disease • • Simple analgesics NSAID – mechanism of action •Inhibition of cyclo-oxigenase • Simple analgesics NSAID – side effects •Gastric irritation •NSAID sensitive asthma •Renal dysfunction – analgesic nefropathy •Antiplatelet function •Hepatotoxicity • •Drug interaction – warfarin, lithium • • • Aspirin Paracetamol Chemistry Acetic acid Paraaminophenol Mechanism of action Inhibition of COX 1 ? COX 3 inhib Metabolism Estrases in gut wall, liver Liver Toxicity Hepatic/renal inpairment GI upset GI upset Trombocytopenia Rayes syndrome in kids Liver necrosis Dose 300 – 900 mg every 6 h 1 g every 6 h Route of administration orally PO/PR/IV Simple analgesics Other NSAIDs •Ibuprofen – the lowest risk of GI upset •Indomethacin, Diclofenac – mainly antiinflamatory effect •Metamizole –Novalgin •Aspirin and NSAIDs are not contraindicated for regional anesthesia SUMMARY – simple analgesics •Aspirin, Paracetamol •NSAID •MOA – inhibition of COX •Renal, gastric, hepatic side effects •Can trigger NSAID sensitive asthma • Opiods •MORPHEUS- GREAK GOD OF DREAMS Definitions •Opiate : naturally occuring substance with morphine-like properties •Opioid – synthetic substance •Narcotic – from greek word ‘ numb’ Opiods Opioids – mechanism of action •Via opioid receptors ▫m - receptor ▫k - receptor ▫d - receptor Opioids - dose – response curve Opioids - dose – response curve Uses and routes of administration •Analgesics •Anti - tussive •Anti – diarrhoea • •Intravenously •Intramuscularly •Oral, Buccal, rectal •Transdermal - Patches •Epidural/intrathecal • Opiods Opioids - effects •Brain: ▫Analgesia, sedation ▫Respiratory depression ▫Euphoria and dysphoria ▫Addiction, tolerance ▫Nausea and vomiting •Eyes ▫Meiosis •Cardiovascular system ▫ Hypotension, bradycardia •Respiratory system ▫Anti tussive effect •GI tract ▫spastic immobility •Skin ▫Pruritus – histamine release •Bladder ▫Urinary retention Opioids - effects Commonly used opioids Dose Elimination ½ life Metabolism Comment Sufentanyl 0.1 mg/kg 50 min liver Faster onset then fentanyl Fentanyl 1-2 mg/kg 190 min liver Neurosurgery, patches Alfentanyl 5 – 25 mg/kg 100 min liver Faster onset then sufentanyl Remifentanyl 0.05 – 2 mg/kg 10 min Plasma and tissue esterases Infusion only, very short context sensit. ½ life Opiods Naloxone •Pure opioid anatagonist at m, d and k - receptors •Used in opioid overdose •Dose : 1- 4 mg/kg •Duration of action 30 – 40 min •! Often shorter then duration of action of opioid, need for repeated doses Opiods Naloxone – dose – response curve Multimodal analgesia SUMMARY – opioids •Morphine, Fentanyl, Sufentanyl, Alfentanyl •MOA – via opioid receptors •Used for analgesia, anti – tussive, anti – diarrhoea •Side effects : respir. depression, tolerance, constipation, nausea + vomiting •Opioid overdose reversal – Naloxone •Multimodal analgesia – simple analgesics + opioids • SUMMARY •Triad of anaesthesia ▫Analgesia ▫Anaesthesia ▫Muscle relaxation ▫ •Choice depends on ▫Patient factors ▫Type of surgery ▫Whether the surgery is elective or emergency Questions ? ana_1_075_anaphylaxis_13_01_med